Cost-effectiveness analysis and formulary decision making in England: Findings from research
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
In a context of rapid technological advances in health care and increasing demand for expensive treatments, local formulary committees are key players in the management of scarce resources. However, little is known about the information and processes used when making decisions on the inclusion of new treatments. This paper reports research on the use of economic evaluations in technology coverage decisions in England, although the findings have a relevance to other health care systems with devolved responsibility for resource allocation. It reports a study of four local formulary committees in which both qualitative and quantitative data were collected. Our main research finding is that it is an exception for cost-effectiveness analysis to inform technology coverage decisions. Barriers to use include access and expertise levels, concerns relating to the independence of analyses and problems with implementation of study recommendations. Further barriers derive from the constraints on decision makers, a lack of clarity over functions and aims of local committees, and the challenge of disinvestment in medical technologies. The relative weakness of the research-practice dynamics in this context suggests the need for a rethinking of the role of both analysts and decision makers. Our research supports the view that in order to be useful, analysis needs to better reflect the constraints of the local decision-making environment. We also recommend that local decision-making committees and bodies in the National Health Service more clearly identify the 'problems' which they are charged with solving and how their outputs contribute to broader finance and commissioning functions. This would help to establish the ways in which the routine use of cost-effectiveness analysis might become a reality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmann, C., Stoykova, B. A., Nixon, J., Glanville, J. M., Misso, K., & Drummond, M. F. (2002) · Value in Health · doi:10.1046/j.1524-4733.2002.52109.x · Cited by 118
Cited by
Towards understanding the de-adoption of low-value clinical practices: a scoping review
Niven, D. J., Mrklas, K. J., Holodinsky, J. K., Straus, S. E., Hemmelgarn, B. R., Jeffs, L. P., & Stelfox, H. T. (2015) · BMC Medicine · doi:10.1186/s12916-015-0488-z · Cited by 369
Priority-setting and rationing in healthcare: Evidence from the English experience
Robinson, S., Williams, I., Dickinson, H., Freeman, T., & Rumbold, B. (2012) · Social Science & Medicine · doi:10.1016/j.socscimed.2012.09.014 · Cited by 112
“The risk is that priority-setting is not embedded within the broader organisational (and inter-organisational) systems (Williams and Bryan, 2007).”
BackgroundSelf-citationWhat counts and how to count it: Physicians’ constructions of evidence in a disinvestment context
Hodgetts, K., Elshaug, A. G., & Hiller, J. E. (2012) · Social Science & Medicine · doi:10.1016/j.socscimed.2012.08.016 · Cited by 27
“…rhetorical, argumentative nature of physicians’ contributions affirms the importance of opening the ‘black box’ of health policy decisionmaking particularly in contentious areas where stakeholder contributions are vital, yet processes for incorporating them remain unclear (Williams & Bryan, 2007).”
BackgroundInfluentialMerlo, G., Page, K., Zardo, P., & Graves, N. (2019) · Applied Health Economics and Health Policy · doi:10.1007/s40258-019-00477-4 · Cited by 10
Metadata
- Authors
- Williams, I. P., & Bryan, S.
- Venue
- Social Science & Medicine
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 65
- Issue
- 10
- Pages
- 2116-2129
- ISSN
- 0277-9536 (ISSN-L)
- OpenAlex
- W1988905542
- Cited by
- 62
- References
- 1
- FWCI
- 9.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.